VAERS reports by lot

Pfizer COVID-19 lot HG4628: VAERS reports

79 VAERS reports list lot HG4628 as a Pfizer COVID-19 vaccine, received between 2023-09-22 and 2024-09-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
79
Reports
11%
Marked serious
0
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological5519%
General / Systemic (non-local)5218%
Injection-site / Local reaction4014%
Gastrointestinal3512%
Cardiac / Cardiovascular3111%
Musculoskeletal238%
Dermatological (non-injection-site)207%
Allergic / Anaphylactic176%
Thrombotic / Hematological52%
Respiratory41%
Psychiatric / Neuropsychiatric21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Massachusetts11
Pennsylvania9
North Carolina7
New York6
Virginia6
California5
New Hampshire4
Connecticut3
New Jersey3
Ohio3
Minnesota2
Florida2

Reports by month received

2023-0910
2023-1016
2023-119
2023-1213
2024-0110
2024-023
2024-032
2024-041
2024-0613
2024-071
2024-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.